Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Taniguchi

Showing results (41-50 of 171) with videos related to

Pageof 18
Sort By:
Pharmacology, Biochemistry, and Behavior|August 13, 2019
Antipsychotic-like effects of a novel phosphodiesterase 10A inhibitor T-251 in rodentsMisae Takakuwa, Yumi Watanabe, Kiichi Tanaka, et al.
International Journal of Clinical Oncology|April 18, 2013
Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosisNaohiro Watanabe, Hiroyuki Taniguchi, Yasuhiro Kondoh, et al.
Internal Medicine (Tokyo, Japan)|October 9, 2010
Noninvasive ventilation in patients with acute exacerbation of pulmonary tuberculosis sequelaeHiromichi Aso, Yasuhiro Kondoh, Hiroyuki Taniguchi, et al.
Internal Medicine (Tokyo, Japan)|March 4, 2016
Clinical Experience of the Long-term Use of Pirfenidone for Idiopathic Pulmonary FibrosisMasashi Bando, Hiroyoshi Yamauchi, Takashi Ogura, et al.
Journal of Pharmacological Sciences|January 12, 2008
Pharmacological characterization of T-2328, 2-fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile dihydrochloride, as a brain-penetrating antagonist of tachykinin NK1 receptorYumi Watanabe, Hidetoshi Asai, Taketoshi Ishii, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 19, 2007
[Primary pulmonary cryptococcosis: a case series of 9 patients]Koji Sakamoto, Hiromichi Aso, Toshiki Yokoyama, et al.
Journal of Pain & Palliative Care Pharmacotherapy|September 6, 2013
Opioid use in end-of-life care in patients with interstitial pneumonia associated with respiratory worseningHiroaki Tsukuura, Koichi Nishimura, Hiroyuki Taniguchi, et al.
International Journal of Clinical Oncology|July 4, 2012
Drug-induced lung injury associated with sorafenib: analysis of all-patient post-marketing surveillance in JapanYuka Horiuchi-Yamamoto, Akihiko Gemma, Hiroyuki Taniguchi, et al.
Respiratory Research|June 30, 2009
Soy consumption and risk of COPD and respiratory symptoms: a case-control study in JapanFumi Hirayama, Andy H Lee, Colin W Binns, et al.
Internal Medicine (Tokyo, Japan)|August 20, 2013
Predictors of the need to initiate noninvasive ventilation in stable outpatients with acute exacerbation of chronic obstructive pulmonary diseaseShu Taga, Hiroyuki Taniguchi, Naohiro Watanabe, et al.
Pageof 18

Showing results (41-50 of 171) with videos related to

Sort By:
Pageof 18
Pharmacology, Biochemistry, and Behavior|August 13, 2019
Antipsychotic-like effects of a novel phosphodiesterase 10A inhibitor T-251 in rodentsMisae Takakuwa, Yumi Watanabe, Kiichi Tanaka, et al.
International Journal of Clinical Oncology|April 18, 2013
Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosisNaohiro Watanabe, Hiroyuki Taniguchi, Yasuhiro Kondoh, et al.
Internal Medicine (Tokyo, Japan)|October 9, 2010
Noninvasive ventilation in patients with acute exacerbation of pulmonary tuberculosis sequelaeHiromichi Aso, Yasuhiro Kondoh, Hiroyuki Taniguchi, et al.
Internal Medicine (Tokyo, Japan)|March 4, 2016
Clinical Experience of the Long-term Use of Pirfenidone for Idiopathic Pulmonary FibrosisMasashi Bando, Hiroyoshi Yamauchi, Takashi Ogura, et al.
Journal of Pharmacological Sciences|January 12, 2008
Pharmacological characterization of T-2328, 2-fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile dihydrochloride, as a brain-penetrating antagonist of tachykinin NK1 receptorYumi Watanabe, Hidetoshi Asai, Taketoshi Ishii, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 19, 2007
[Primary pulmonary cryptococcosis: a case series of 9 patients]Koji Sakamoto, Hiromichi Aso, Toshiki Yokoyama, et al.
Journal of Pain & Palliative Care Pharmacotherapy|September 6, 2013
Opioid use in end-of-life care in patients with interstitial pneumonia associated with respiratory worseningHiroaki Tsukuura, Koichi Nishimura, Hiroyuki Taniguchi, et al.
International Journal of Clinical Oncology|July 4, 2012
Drug-induced lung injury associated with sorafenib: analysis of all-patient post-marketing surveillance in JapanYuka Horiuchi-Yamamoto, Akihiko Gemma, Hiroyuki Taniguchi, et al.
Respiratory Research|June 30, 2009
Soy consumption and risk of COPD and respiratory symptoms: a case-control study in JapanFumi Hirayama, Andy H Lee, Colin W Binns, et al.
Internal Medicine (Tokyo, Japan)|August 20, 2013
Predictors of the need to initiate noninvasive ventilation in stable outpatients with acute exacerbation of chronic obstructive pulmonary diseaseShu Taga, Hiroyuki Taniguchi, Naohiro Watanabe, et al.
Pageof 18